EIM
AERI

Essex Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Essex Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100,000
Closed -$1.35M – 458
2020
Q1 		$1.35M Hold
100,000
– – 0.27% 118
2019
Q4 		$2.42M Buy
+100,000
New +$2.07M 0.3% 103
2019
Q3 		– Sell
-52,873
Closed -$1.56M – 513
2019
Q2 		$1.56M Sell
52,873
-8,862
-14% -$341K 0.21% 156
2019
Q1 		$2.93M Sell
61,735
-31,843
-34% -$1.4M 0.43% 58
2018
Q4 		$3.38M Buy
93,578
+26,184
+39% +$1.23M 0.53% 45
2018
Q3 		$4.15M Hold
67,394
– – 0.49% 49
2018
Q2 		$4.55M Sell
67,394
-9,678
-13% -$541K 0.57% 42
2018
Q1 		$4.18M Hold
77,072
– – 0.55% 45
2017
Q4 		$4.61M Sell
77,072
-3,294
-4% -$200K 0.61% 35
2017
Q3 		$3.91M Buy
80,366
+3,659
+5% +$200K 0.53% 43
2017
Q2 		$4.03M Sell
76,707
-10,955
-12% -$510K 0.58% 40
2017
Q1 		$3.98M Sell
87,662
-28,653
-25% -$1.28M 0.62% 38
2016
Q4 		$4.4M Sell
116,315
-37,790
-25% -$1.43M 0.73% 32
2016
Q3 		$5.82M Buy
154,105
+46,405
+43% +$1.02M 0.94% 26
2016
Q2 		$1.9M Buy
107,700
+88,880
+472% +$1.44M 0.32% 84
2016
Q1 		$229K Buy
18,820
+5,000
+36% +$79.1K 0.04% 291
2015
Q4 		$337K Sell
13,820
-30,000
-68% -$700K 0.05% 265
2015
Q3 		$777K Buy
+43,820
New +$794K 0.13% 171
2015
Q2 		– Sell
-283,725
Closed -$8.89M – 347
2015
Q1 		$8.89M Buy
283,725
+73,329
+35% +$2.13M 1.24% 19
2014
Q4 		$6.14M Sell
210,396
-2,231
-1% -$56.6K 0.89% 29
2014
Q3 		$4.4M Buy
212,627
+93,582
+79% +$1.85M 0.67% 44
2014
Q2 		$2.95M Buy
119,045
+3,704
+3% +$64.2K 0.43% 61
2014
Q1 		$2.44M Buy
115,341
+83,277
+260% +$1.68M 0.36% 80
2013
Q4 		$576K Buy
+32,064
New +$418K 0.08% 257

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Essex Investment Management's AERI Position: Q2 2020 in Review

Essex Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 100,000 shares — an estimated $1.35M sold.

Essex Investment Management first reported a position in AERI in Q4 2013 and held it in 24 quarters. The position peaked at $8.89M in Q1 2015. 155 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

  • Essex Investment Management reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Essex Investment Management sold 100,000 Aerie Pharmaceuticals shares in Q2 2020, an estimated $1.35M.
  • Essex Investment Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 24 quarters.
  • Essex Investment Management's Aerie Pharmaceuticals position peaked at $8.89M in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Essex Investment Management's 13F filing for Q2 2020, filed 4 Aug 2020.